Wang, TianDuo
Chen, Yuanxin
Ronald, John. A.
Funding for this research was provided by:
Prostate Cancer Canada (D2017-1970)
Article History
Received: 17 November 2018
Revised: 15 January 2019
Accepted: 30 January 2019
First Online: 13 March 2019
Compliance with ethical standards
:
: JAR is co-inventor on a US patent called “Tumour-specific minicircles for cancer screening” (Patent number 9534248; 2017/1/3), which describes the invention of tumour-activatable minicircles for cancer detection. This patent has been licensed by the start-up company Earli, Inc., and JAR holds shares and is a consultant of this company. The remaining authors declare that they have no conflict of interest.